Each blisterpack ofVelsipitycontains_____or_____tabletsVelsipity isindicated fortreating___________Themechanismof action ofVelsipity is____________________willadvise the CWif the patientmeets bridgingcriteriaThe genericname ofVelsipity is___________FCM mustescalate to______forapproval if apatient does notmeet criteriaList onesymptom ofUC_________Onecommonside effect ofVelsipity is_________Each bottle ofVelsipity willcontain______tabletsAnothercommon sideeffect of Velsipityis_____________If more than___consecutivedoses are missednotify HCP fortreatment re-initiationSome patientsrequire a__________thefirst time theytake VelsipityPatients with_________should haveregular eyeexamsTherecommendeddoseofVelsipity is______The Velsipitywelcome call isperformedby__________Patients shouldnot_______theirdose of Velsipityto make up for aforgotten dosePatientswith__________should haveregular eyeexamsVelsipityshould bestored at___________Velsipity isadministeredvia___________Velsipity hassimilarprogramofferings to____________State one pre-treatmentserviceavailable topatients__________________isa very commonadverse reactionLong-termbridging may beapproved for_______monthsUC is a chronicinflammatorydisease thataffectsthe________Each blisterpack ofVelsipitycontains_____or_____tabletsVelsipity isindicated fortreating___________Themechanismof action ofVelsipity is____________________willadvise the CWif the patientmeets bridgingcriteriaThe genericname ofVelsipity is___________FCM mustescalate to______forapproval if apatient does notmeet criteriaList onesymptom ofUC_________Onecommonside effect ofVelsipity is_________Each bottle ofVelsipity willcontain______tabletsAnothercommon sideeffect of Velsipityis_____________If more than___consecutivedoses are missednotify HCP fortreatment re-initiationSome patientsrequire a__________thefirst time theytake VelsipityPatients with_________should haveregular eyeexamsTherecommendeddoseofVelsipity is______The Velsipitywelcome call isperformedby__________Patients shouldnot_______theirdose of Velsipityto make up for aforgotten dosePatientswith__________should haveregular eyeexamsVelsipityshould bestored at___________Velsipity isadministeredvia___________Velsipity hassimilarprogramofferings to____________State one pre-treatmentserviceavailable topatients__________________isa very commonadverse reactionLong-termbridging may beapproved for_______monthsUC is a chronicinflammatorydisease thataffectsthe________

Velsipity BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Each blister pack of Velsipity contains _____or _____tablets
  2. Velsipity is indicated for treating ___________
  3. The mechanism of action of Velsipity is ___________
  4. _________will advise the CW if the patient meets bridging criteria
  5. The generic name of Velsipity is ___________
  6. FCM must escalate to ______for approval if a patient does not meet criteria
  7. List one symptom of UC_________
  8. One common side effect of Velsipity is _________
  9. Each bottle of Velsipity will contain ______tablets
  10. Another common side effect of Velsipity is _____________
  11. If more than ___consecutive doses are missed notify HCP for treatment re-initiation
  12. Some patients require a __________the first time they take Velsipity
  13. Patients with _________ should have regular eye exams
  14. The recommended doseof Velsipity is ______
  15. The Velsipity welcome call is performed by__________
  16. Patients should not _______their dose of Velsipity to make up for a forgotten dose
  17. Patients with__________ should have regular eye exams
  18. Velsipity should be stored at ___________
  19. Velsipity is administered via ___________
  20. Velsipity has similar program offerings to ____________
  21. State one pre-treatment service available to patients______
  22. ____________is a very common adverse reaction
  23. Long-term bridging may be approved for _______months
  24. UC is a chronic inflammatory disease that affects the________